ASCRS Releases Position Statement on Two Established Ophthalmic Practices | ASCRS
Committee Report
ASCRS Releases Position Statement on Two Established Ophthalmic Practices
August 2015
You must be logged in to view this content

This resource is only available for ASCRS Members. Please log in using the teal "Login" button in the top right-hand corner to log in.

Statement Details

The American Society of Cataract and Refractive Surgery (ASCRS) has released an official position statement opposing directives that restrict two well-established pre-surgical ophthalmic practices: the use of diluted povidone-iodine solution for topical infection prophylaxis and the use of multidose topical eye drops on multiple patients. The position statement, developed by the ASCRS Cataract Clinical Committee, comes in the wake of some surgery centers being compelled to cease certain long accepted topical treatments for preoperative patients.

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.